Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q1 Virtual Investor Summit (March 2021)
23 slides from Bioceres Crop Solutions's conference presentation, March 2021
Slide 1: Investor Presentation
Investor Presentation NYSE: BIOX March 2021
Slide 2: Disclaimer and Forward-looking Statement
Disclaimer and Forward-looking Statement This Presentation is for informational purposes only and does not constitute an offer or invitation to sell, a Financial Information Presentation solicitation of an offer to buy, or a recommendation to purchase any equity, assets, business, debt or other fina
Slide 3: Corporate Overview
Corporate Overview We are a fully-integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality A Compelling Biotech Story Grower- and consumer-oriented solutions Biotech platform with high-impact technologies around sustainable prod
Slide 4: History
History 43 years of experience utilizing multiple technological approaches to develop and commercialize products that enhance crop quality and productivity Regulatory Bioceres approval for consolidates HB4® wheat in 80% of Rizobacter Argentina Regulatory Digital platform Regulatory for crop HB4® soy
Slide 5: Snapshot: Leading positions and multiple growth levers
Snapshot Leading positions and multiple growth levers By the Numbers Operational Revenue & Main Growth $167.9M 1st to achieve drought-tolerant wheat and soy Business Segments Gross Margin1 Lever Revenues¹ 23% market share in soybean biologicals CROP PROTECTION $92.7M | 42% Adjuvant expansion - Brazi
Slide 6: The HB4 Technology Performance
The HB4® Technology Performance Bioceres’ proprietary HB4® technology is the only available technology for drought tolerance in soybean-wheat cropping systems EcoSoy EcoWheat CONTROL CONTROL Drought & Salinity tolerance Drought & Salinity tolerance +13% impact in yields +19.5% impact in yields 6
Slide 7: HB4 Value Creation to Growers
HB4® Value Creation to Growers Total market 35M ha 36M ha 24M ha Additional crop value created by HB4® HIGH LOW Combination of EcoWheat and EcoSoy for Argentina. Brazil and US, EcoSoy only 7
Slide 8: HB4 Market Access
HB4® Market Access Regulatory approval in over 80% of the global soybean market (AR, BR and US) First approval for drought tolerance events in wheat Regulatory approval obtained Approval requested Soybean Wheat Soybean Wheat ¹ The commercialization of HB4® wheat in Argentina is subject to Brazil app
Slide 9: The Integrated Seed Product Concept
The Integrated Seed Product Concept GERMPLASM TRAITS HB4® Drought tolerance technology FUNGICIDE & INSECTICIDE Customized microbial solutions POLYMER BIOLOGICALS Top tier germoplasm EXTERNAL FLOWABILITY Digital solutions AGENT 9
Slide 10: Addressing Agriculture and Climate Change
Addressing Agriculture and Climate Change We will need 2.1x planets by 2050 Contribution to Green House Gas Emmissions1 Effects of climate change on Agriculture2 24% 21% Agriculture, Forestry Industry STUDIES WITH GIVEN YIELD RANGE (%) and other land use 50 0 14% 50 Transport 2010-2029 2030-2049 205
Slide 11: The HB4 Program: Scalable sustainability
The HB4® Program Scalable sustainability Identity preserved production system to multiply The Program establishes good agricultural practices HB4 seeds with selected growers for growers, which enhanced by our technologies, significantly contribute to the transition of agriculture towards carbon neut
Slide 12: HB4 Program
HB4 Program Inventory ramp-up on track; scaling rate ~25x-30x YoY1 ~7K Hectares Harvest 50 100% Customer repeat rate for Potential Seed Availability Sites next cycle For Next Season $1.4M Contributed goods2 ~60K-130K3 Wheat 58% Gross Margin 2 3 Hectares Varieties Regions ~23K Hectares Planted 148 Gr
Slide 13: Company Performance
Company Performance Proven track-record in delivering solid financial performance Revenues Adjusted EBITDA ($M) ($M) 173 1652 161 47 41 42 134 87 22 14 FY17 FY18 FY19 FY20 2Q21 LTM FY17 FY18 FY19 FY20 2Q21 LTM Adjusted EBITDA Margin (%) 16 16 25 27 26 ¹ Financials presented correspond to As Reported
Slide 14: Debt Profile, Cash Position & Generation
Debt Profile, Cash Position & Generation Strong cash position to support high season working capital needs, HB4 Program inventory ramp-up • EBITDA 2Q21 LTM. Slightly up 2% compared to 2Q20 LTM, with a 26% EBITDA margin • CAPEX. Limited capital expenditure requirements supported by well-invested asse
Slide 15: Main Corporate Entities
Main Corporate Entities 52% Public investors Bioceres Crop Solutions Corp and others 40.3M (BIOX) Outstanding shares Bioceres LLC (NYSE: BIOX) (USA) 48% 100% 80% 100% Rizobacter 9 international Bioceres S.A. (ARG) subsidiaries Semillas S.A. (ARG) 100% 50% Bolivia Colombia Brazil 50% USA Paraguay Ver
Slide 16: Exhibits
” Y, 7 OCER ES ' CROP SOLUTIONS —
Slide 17: Product Portfolio
Product Portfolio Segment Crop Protection Crop Nutrition Seed and Integrated Products Subsegments Adjuvants Insecticides & Inoculants & Micro-beaded Seed Treatments Seed Traits & Fungicides Biofertilizers Fertilizers Germplasm Increase Full range of pest Nitrogen-fixing Micro-beaded Full seed treatm
Slide 18: IP Asset Portfolio
IP Asset Portfolio A well-developed and strong portfolio of patents, trademarks and plant variety protections 214 Traits include improved yield, 49 165 Patents and drought tolerance, NUE, WUE Genes currently Licenses link to crop- Patents applications as holder and TREF technologies, delayed protect
Slide 19: Diversified Infrastructure Portfolio
Diversified Infrastructure Portfolio Limited Capex Requirements Reflects Well-Invested Asset Base Seed and integrated Crop protection Crop nutrition products Operational capabilities in Fully operational 50,000 ton micro Proprietary brands in leading seed Argentina and Brazil for production beaded f
Slide 20: Management
Management Federico Trucco, Chief Executive Officer Federico is the son of Víctor Trucco and María Cristina Fossaroli, both descending from Italian immigrants that settled as farmers in the central-south region of Santa Fe province. He originally joined Bioceres as a research leader for one of its R
Slide 21: Unaudited Consolidated Statement of Comprehensive Income
Unaudited Consolidated Statement of Comprehensive Income Three-month period Three-month period Six-month period Six-month period Figures in $ Millions ended 12/31/2020 ended 12/31/2019 ended 12/31/2020 ended 12/31/2019 Total revenue 48.7 63.0 91.1 99.2 Cost of sales (25.1) (33.0) (48.2) (53.3) Gross
Slide 22: Unaudited Consolidated Statement of Financial Position
Unaudited Consolidated Statement LIABILITIES 12/31/2020 06/30/2020 of Financial Position CURRENT LIABILITIES Figures in $ Millions Trade and other payables 63.3 57.3 ASSETS 12/31/2020 06/30/2020 Borrowings 89.5 63.7 Employee benefits and social security 4.1 4.5 CURRENT ASSETS Deferred revenue and ad
Slide 23: Contact Us
Contact Us Investor Relations Investorrelations@biocerescrops.com (54) 0341 4861100 Investors.biocerescrops.com 26
Bioceres Crop Solutions — Q1 Virtual Investor Summit (March 2021) on 6ix